Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
JStar Capital Investments is a venture capital firm founded to focus on the med-tech healthcare sector. Established in the United States, the firm manages over $100 million in capital and is dedicated to reshaping the healthcare landscape through strategic investments in innovative medical technologies. JStar Capital aims to support late-stage, high-potential healthcare companies that are poised for imminent monetization or strategic exit.
The firm combines capital with clinical insights to navigate the complexities of healthcare delivery. JStar Capital emphasizes the importance of clinical validation and a clear path to scalable adoption in its investment strategy. The firm has built a reputation for its focus on breakthrough medical technologies and services, particularly in sectors such as cardiovascular protection, orthopedic technologies, and biopharma solutions.
JStar Capital's team consists of experienced professionals with backgrounds in healthcare and finance, enabling them to provide strategic support to portfolio companies. The firm operates from its base in Austin, Texas, and has established a network of healthcare and financial experts to assist in the growth of its investments.
JStar Capital Investments specializes in investing in breakthrough medical technologies and services across several sectors, including healthcare, biotech, digital health, and medical devices. The firm primarily targets late-stage companies that demonstrate clinical validation and a clear path to scalable adoption. JStar Capital focuses on sectors such as cardiovascular and stroke protection, orthopedic technologies, biopharma solutions, and digital health innovations.
The firm typically invests in companies that are positioned for imminent monetization or strategic exit, emphasizing the importance of clinical impact and commercialization readiness. JStar Capital seeks to back healthcare innovations that improve patient outcomes and lower costs. Their investment strategy is characterized by a preference for technologies that support minimally invasive procedures and optimize outpatient care.
JStar Capital's check sizes are not publicly disclosed, but the firm is known for its strategic support, which includes leveraging its network of healthcare and financial experts to help portfolio companies navigate regulatory, reimbursement, and adoption pathways.
JStar Capital's portfolio includes several notable companies that exemplify its focus on innovative medical technologies:
These companies represent JStar Capital's commitment to investing in technologies that enhance patient safety, improve healthcare delivery, and drive innovation in the medical field.
Evan Pritchard - Senior Managing Director & Co-Founder. Pritchard has over two decades of experience in medical technology, having worked with Fortune 500 companies and pre-revenue startups. His expertise lies in addressing unmet clinical needs through venture capital and private equity.
Jared Leger - Managing Director & Co-Founder. Leger is a healthcare executive and licensed registered nurse, focusing on healthcare delivery and the growth of healthcare enterprises.
Dr. Kevin Lewis - Director. Lewis is a physician advisor with a background in family medicine, providing clinical insights to the firm.
Dr. Vinh Nguyen - Director. Nguyen is a cardiologist and medical advisor, board certified in internal medicine, cardiovascular medicine, and nuclear cardiology.
Dr. David Nelson - Director. Nelson's specific background details are not provided, but he contributes to the firm's medical advisory capabilities.
Beau Barnes - CFO. Barnes oversees the financial operations of JStar Capital, ensuring effective capital management.
Jessica Jasso - Executive Operations Director. Jasso plays a key role in the operational aspects of the firm.
Additionally, JStar Capital has a team of strategic business advisors, including David Narrow, John Pesce, Joe Loy, Jerry DeVries, Dr. John Schlitt, Dr. Scott Gordon, and Dr. Buck Cross, who provide valuable insights and guidance.
To pitch JStar Capital Investments, founders should visit their website at jstarinvestments.com. It is recommended to include a comprehensive overview of the company's clinical validation, commercialization strategy, and market potential in the pitch deck. While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the firm's focus on late-stage investments.
Warm introductions are preferred, as they can facilitate a more favorable reception of the pitch. Founders should ensure that their presentations are clear, concise, and focused on the unique value proposition of their healthcare innovations.
On October 1, 2025, JStar Capital Investments led a Series B funding round for Significo, a health AI and digital therapeutics company, which resulted in a $100 million valuation for the company. This investment highlights JStar's commitment to supporting innovative healthcare solutions.
In recent months, JStar Capital has expanded its portfolio with notable investments in companies such as Sonavex and Adhere Plus, which are developing advanced medical technologies aimed at improving patient care and outcomes.
What investment criteria does JStar Capital look for?
JStar Capital focuses on late-stage healthcare companies that demonstrate clinical validation and a clear path to scalable adoption. They prioritize innovations that improve patient outcomes and lower costs.
How can I apply or pitch to JStar Capital?
Founders can pitch JStar Capital through their website at jstarinvestments.com. It is advisable to include detailed information about the company's clinical validation and commercialization strategy in the pitch.
What makes JStar Capital different from other investors?
JStar Capital combines capital with clinical insights, leveraging a network of healthcare and financial experts to assist portfolio companies in navigating regulatory and reimbursement challenges.
What is the geographic scope of JStar Capital's investments?
The firm primarily invests in the United States, focusing on healthcare and biotech sectors.
What is the typical check size for investments?
Specific check sizes are not publicly disclosed, but JStar Capital is known for making significant investments in late-stage companies.
What kind of post-investment involvement does JStar Capital have?
JStar Capital provides strategic support to its portfolio companies, helping them navigate the complexities of healthcare delivery and commercialization.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.